The Effects of Telmisartan on Intra-Islet Microvasculature in Db/db Mice

邵加庆,顾萍,杜宏,卢斌,李洁,彭丽,王燕燕,赵明,王坚

DOI: https://doi.org/10.3969/j.issn.1009-0126.2010.08.019

2010-01-01

Abstract:Objective To explore the effects of telmisartan on intra-islet microvasculature in db/db mice through blocking renin-angiotensin system.Methods Twenty-two 8 weeks old db/db mice were randomized to telmisartan group(5 mg/kg telmisartan,n = 11) and placebo group (n = 11), the drugs were given via gavage for 6 weeks.Other 11 age-matched db/m mice were concurrently treated with placebo as non-diabetic controls.Body weight and blood glucose were measured every week.After 6 weeks' treatment,intraperitoneal glucose tolerance test was performed,immunohis-tochemical examination of pancreas was carried out to analyze expression of CD31 in microvessels of islet.Results After six weeks' telmisartan treatment,the fasting blood glucose significantly decreased,insulin sensitivity index significantly increased (P 0.05).AUC of glucose curve decreased (P 0.05) and AUC of 0-30 min insulin curve increased (P 0.05) in telmisartan group compared with placebo group.Telmisartan treatment greatly increased staining intensity of CD31 in islets.Conclusions Telmisartan treatment remarkably increased intra-islet microvasculature volume,and improved early-phase insulin secretion,thus protected β-cell function.